MPN are clonally driven by mutually exclusive mutations in the Janus kinase 2 (JAK2), calreticulin (CALR), or myeloproliferative leukemia virus (MPL) genes [32]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.